nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP3A4—type 2 diabetes mellitus	0.195	1	CbGaD
Pentobarbital—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0867	0.17	CbGbCtD
Pentobarbital—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0457	0.0896	CbGbCtD
Pentobarbital—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0388	0.0762	CbGbCtD
Pentobarbital—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0388	0.0762	CbGbCtD
Pentobarbital—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0358	0.0703	CbGbCtD
Pentobarbital—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0346	0.0679	CbGbCtD
Pentobarbital—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0291	0.0572	CbGbCtD
Pentobarbital—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.026	0.0509	CbGbCtD
Pentobarbital—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0238	0.0466	CbGbCtD
Pentobarbital—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0208	0.0407	CbGbCtD
Pentobarbital—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0199	0.039	CbGbCtD
Pentobarbital—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0188	0.0368	CbGbCtD
Pentobarbital—CYP2C19—Losartan—type 2 diabetes mellitus	0.0182	0.0357	CbGbCtD
Pentobarbital—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0142	0.0279	CbGbCtD
Pentobarbital—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0136	0.0268	CbGbCtD
Pentobarbital—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0136	0.0268	CbGbCtD
Pentobarbital—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0129	0.0253	CbGbCtD
Pentobarbital—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00961	0.0189	CbGbCtD
Pentobarbital—CYP3A4—Losartan—type 2 diabetes mellitus	0.00879	0.0172	CbGbCtD
Pentobarbital—CHRNA4—autonomic nervous system—type 2 diabetes mellitus	0.00204	0.186	CbGeAlD
Pentobarbital—CHRNA4—peripheral nervous system—type 2 diabetes mellitus	0.00148	0.134	CbGeAlD
Pentobarbital—GRIK2—nerve—type 2 diabetes mellitus	0.00143	0.13	CbGeAlD
Pentobarbital—CHRNA4—nerve—type 2 diabetes mellitus	0.00115	0.105	CbGeAlD
Pentobarbital—Thiamylal—KCNJ11—type 2 diabetes mellitus	0.000921	0.321	CrCbGaD
Pentobarbital—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000893	0.00548	CcSEcCtD
Pentobarbital—Tension—Glimepiride—type 2 diabetes mellitus	0.000863	0.0053	CcSEcCtD
Pentobarbital—Tension—Sitagliptin—type 2 diabetes mellitus	0.00086	0.00528	CcSEcCtD
Pentobarbital—Nervousness—Glimepiride—type 2 diabetes mellitus	0.000854	0.00524	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Losartan—type 2 diabetes mellitus	0.000851	0.00523	CcSEcCtD
Pentobarbital—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.000851	0.00523	CcSEcCtD
Pentobarbital—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000845	0.00519	CcSEcCtD
Pentobarbital—Syncope—Glipizide—type 2 diabetes mellitus	0.000845	0.00519	CcSEcCtD
Pentobarbital—Nausea—Miglitol—type 2 diabetes mellitus	0.000842	0.00517	CcSEcCtD
Pentobarbital—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.000828	0.00508	CcSEcCtD
Pentobarbital—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.000825	0.00506	CcSEcCtD
Pentobarbital—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00082	0.00504	CcSEcCtD
Pentobarbital—Agitation—Glimepiride—type 2 diabetes mellitus	0.000808	0.00496	CcSEcCtD
Pentobarbital—Angioedema—Glimepiride—type 2 diabetes mellitus	0.000803	0.00493	CcSEcCtD
Pentobarbital—Rash—Tolbutamide—type 2 diabetes mellitus	0.000803	0.00493	CcSEcCtD
Pentobarbital—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.000801	0.00492	CcSEcCtD
Pentobarbital—Anxiety—Glipizide—type 2 diabetes mellitus	0.000799	0.00491	CcSEcCtD
Pentobarbital—Headache—Tolbutamide—type 2 diabetes mellitus	0.000798	0.0049	CcSEcCtD
Pentobarbital—Constipation—Repaglinide—type 2 diabetes mellitus	0.000795	0.00488	CcSEcCtD
Pentobarbital—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000791	0.00486	CcSEcCtD
Pentobarbital—Tension—Bromocriptine—type 2 diabetes mellitus	0.000778	0.00478	CcSEcCtD
Pentobarbital—Confusional state—Glipizide—type 2 diabetes mellitus	0.000775	0.00476	CcSEcCtD
Pentobarbital—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.000773	0.00475	CcSEcCtD
Pentobarbital—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00077	0.00473	CcSEcCtD
Pentobarbital—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000766	0.00471	CcSEcCtD
Pentobarbital—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000766	0.00471	CcSEcCtD
Pentobarbital—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000761	0.00468	CcSEcCtD
Pentobarbital—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000757	0.00465	CcSEcCtD
Pentobarbital—Shock—Glipizide—type 2 diabetes mellitus	0.000757	0.00465	CcSEcCtD
Pentobarbital—Ataxia—Losartan—type 2 diabetes mellitus	0.000755	0.00464	CcSEcCtD
Pentobarbital—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.000751	0.00461	CcSEcCtD
Pentobarbital—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000746	0.00458	CcSEcCtD
Pentobarbital—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.000744	0.00457	CcSEcCtD
Pentobarbital—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000737	0.00453	CcSEcCtD
Pentobarbital—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000731	0.00449	CcSEcCtD
Pentobarbital—Rash—Tolazamide—type 2 diabetes mellitus	0.000731	0.00449	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.00073	0.00448	CcSEcCtD
Pentobarbital—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000729	0.00448	CcSEcCtD
Pentobarbital—Headache—Tolazamide—type 2 diabetes mellitus	0.000726	0.00446	CcSEcCtD
Pentobarbital—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000726	0.00446	CcSEcCtD
Pentobarbital—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000724	0.00444	CcSEcCtD
Pentobarbital—Rash—Linagliptin—type 2 diabetes mellitus	0.000723	0.00444	CcSEcCtD
Pentobarbital—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000723	0.00444	CcSEcCtD
Pentobarbital—Headache—Linagliptin—type 2 diabetes mellitus	0.000719	0.00441	CcSEcCtD
Pentobarbital—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000711	0.00437	CcSEcCtD
Pentobarbital—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00071	0.00436	CcSEcCtD
Pentobarbital—Vomiting—Acarbose—type 2 diabetes mellitus	0.000708	0.00435	CcSEcCtD
Pentobarbital—Shock—Glimepiride—type 2 diabetes mellitus	0.000706	0.00434	CcSEcCtD
Pentobarbital—Rash—Acarbose—type 2 diabetes mellitus	0.000702	0.00431	CcSEcCtD
Pentobarbital—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000702	0.00431	CcSEcCtD
Pentobarbital—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000697	0.00428	CcSEcCtD
Pentobarbital—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000688	0.00423	CcSEcCtD
Pentobarbital—Nausea—Tolazamide—type 2 diabetes mellitus	0.000688	0.00423	CcSEcCtD
Pentobarbital—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000685	0.0042	CcSEcCtD
Pentobarbital—Somnolence—Glipizide—type 2 diabetes mellitus	0.000684	0.0042	CcSEcCtD
Pentobarbital—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000683	0.00419	CcSEcCtD
Pentobarbital—Rash—Nateglinide—type 2 diabetes mellitus	0.000677	0.00416	CcSEcCtD
Pentobarbital—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000676	0.00415	CcSEcCtD
Pentobarbital—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000673	0.00413	CcSEcCtD
Pentobarbital—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000671	0.00412	CcSEcCtD
Pentobarbital—Angioedema—Glyburide—type 2 diabetes mellitus	0.000663	0.00407	CcSEcCtD
Pentobarbital—Nausea—Acarbose—type 2 diabetes mellitus	0.000661	0.00406	CcSEcCtD
Pentobarbital—Constipation—Glipizide—type 2 diabetes mellitus	0.000658	0.00404	CcSEcCtD
Pentobarbital—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000653	0.00401	CcSEcCtD
Pentobarbital—Tension—Gliclazide—type 2 diabetes mellitus	0.000639	0.00392	CcSEcCtD
Pentobarbital—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000638	0.00392	CcSEcCtD
Pentobarbital—Nausea—Nateglinide—type 2 diabetes mellitus	0.000638	0.00392	CcSEcCtD
Pentobarbital—Bradycardia—Metformin—type 2 diabetes mellitus	0.000637	0.00391	CcSEcCtD
Pentobarbital—Shock—Bromocriptine—type 2 diabetes mellitus	0.000637	0.00391	CcSEcCtD
Pentobarbital—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000636	0.0039	CcSEcCtD
Pentobarbital—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000634	0.00389	CcSEcCtD
Pentobarbital—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000632	0.00388	CcSEcCtD
Pentobarbital—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000612	0.00376	CcSEcCtD
Pentobarbital—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000607	0.00373	CcSEcCtD
Pentobarbital—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000605	0.00371	CcSEcCtD
Pentobarbital—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000601	0.00369	CcSEcCtD
Pentobarbital—Agitation—Gliclazide—type 2 diabetes mellitus	0.000598	0.00367	CcSEcCtD
Pentobarbital—Confusional state—Glyburide—type 2 diabetes mellitus	0.000597	0.00366	CcSEcCtD
Pentobarbital—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000595	0.00365	CcSEcCtD
Pentobarbital—GRIK2—retina—type 2 diabetes mellitus	0.000593	0.054	CbGeAlD
Pentobarbital—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000591	0.00363	CcSEcCtD
Pentobarbital—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000591	0.00363	CcSEcCtD
Pentobarbital—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000589	0.00362	CcSEcCtD
Pentobarbital—Rash—Repaglinide—type 2 diabetes mellitus	0.000586	0.0036	CcSEcCtD
Pentobarbital—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000585	0.0036	CcSEcCtD
Pentobarbital—Headache—Repaglinide—type 2 diabetes mellitus	0.000582	0.00358	CcSEcCtD
Pentobarbital—Shock—Glyburide—type 2 diabetes mellitus	0.000582	0.00358	CcSEcCtD
Pentobarbital—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000581	0.00357	CcSEcCtD
Pentobarbital—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000576	0.00353	CcSEcCtD
Pentobarbital—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000572	0.00351	CcSEcCtD
Pentobarbital—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000567	0.00348	CcSEcCtD
Pentobarbital—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000554	0.0034	CcSEcCtD
Pentobarbital—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000554	0.0034	CcSEcCtD
Pentobarbital—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000553	0.0034	CcSEcCtD
Pentobarbital—Hypotension—Glyburide—type 2 diabetes mellitus	0.000553	0.0034	CcSEcCtD
Pentobarbital—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000552	0.00339	CcSEcCtD
Pentobarbital—Nausea—Repaglinide—type 2 diabetes mellitus	0.000552	0.00339	CcSEcCtD
Pentobarbital—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00055	0.00338	CcSEcCtD
Pentobarbital—Angioedema—Valsartan—type 2 diabetes mellitus	0.000547	0.00336	CcSEcCtD
Pentobarbital—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000543	0.00333	CcSEcCtD
Pentobarbital—Angioedema—Orlistat—type 2 diabetes mellitus	0.00054	0.00332	CcSEcCtD
Pentobarbital—Syncope—Valsartan—type 2 diabetes mellitus	0.000536	0.00329	CcSEcCtD
Pentobarbital—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000536	0.00329	CcSEcCtD
Pentobarbital—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000533	0.00328	CcSEcCtD
Pentobarbital—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000529	0.00325	CcSEcCtD
Pentobarbital—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000527	0.00324	CcSEcCtD
Pentobarbital—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000526	0.00323	CcSEcCtD
Pentobarbital—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000522	0.0032	CcSEcCtD
Pentobarbital—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000512	0.00314	CcSEcCtD
Pentobarbital—Dizziness—Glipizide—type 2 diabetes mellitus	0.000509	0.00312	CcSEcCtD
Pentobarbital—Anxiety—Valsartan—type 2 diabetes mellitus	0.000508	0.00312	CcSEcCtD
Pentobarbital—Tension—Irbesartan—type 2 diabetes mellitus	0.000504	0.0031	CcSEcCtD
Pentobarbital—Anxiety—Orlistat—type 2 diabetes mellitus	0.000502	0.00308	CcSEcCtD
Pentobarbital—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000499	0.00307	CcSEcCtD
Pentobarbital—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000497	0.00305	CcSEcCtD
Pentobarbital—Vomiting—Glipizide—type 2 diabetes mellitus	0.000489	0.003	CcSEcCtD
Pentobarbital—Syncope—Metformin—type 2 diabetes mellitus	0.000489	0.003	CcSEcCtD
Pentobarbital—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000488	0.00299	CcSEcCtD
Pentobarbital—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000487	0.00299	CcSEcCtD
Pentobarbital—Rash—Glipizide—type 2 diabetes mellitus	0.000485	0.00298	CcSEcCtD
Pentobarbital—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000484	0.00297	CcSEcCtD
Pentobarbital—CHRNA7—retina—type 2 diabetes mellitus	0.000483	0.044	CbGeAlD
Pentobarbital—Headache—Glipizide—type 2 diabetes mellitus	0.000482	0.00296	CcSEcCtD
Pentobarbital—Shock—Valsartan—type 2 diabetes mellitus	0.00048	0.00295	CcSEcCtD
Pentobarbital—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000479	0.00294	CcSEcCtD
Pentobarbital—Tension—Losartan—type 2 diabetes mellitus	0.000475	0.00292	CcSEcCtD
Pentobarbital—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000475	0.00291	CcSEcCtD
Pentobarbital—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000473	0.0029	CcSEcCtD
Pentobarbital—Agitation—Irbesartan—type 2 diabetes mellitus	0.000472	0.0029	CcSEcCtD
Pentobarbital—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000472	0.0029	CcSEcCtD
Pentobarbital—Nervousness—Losartan—type 2 diabetes mellitus	0.00047	0.00289	CcSEcCtD
Pentobarbital—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00047	0.00288	CcSEcCtD
Pentobarbital—Headache—Pioglitazone—type 2 diabetes mellitus	0.000462	0.00283	CcSEcCtD
Pentobarbital—Syncope—Irbesartan—type 2 diabetes mellitus	0.000461	0.00283	CcSEcCtD
Pentobarbital—Nausea—Glipizide—type 2 diabetes mellitus	0.000457	0.0028	CcSEcCtD
Pentobarbital—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000456	0.0028	CcSEcCtD
Pentobarbital—Hypotension—Valsartan—type 2 diabetes mellitus	0.000456	0.0028	CcSEcCtD
Pentobarbital—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000455	0.00279	CcSEcCtD
Pentobarbital—Constipation—Gliclazide—type 2 diabetes mellitus	0.000454	0.00279	CcSEcCtD
Pentobarbital—Rash—Glimepiride—type 2 diabetes mellitus	0.000452	0.00278	CcSEcCtD
Pentobarbital—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000452	0.00278	CcSEcCtD
Pentobarbital—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000452	0.00277	CcSEcCtD
Pentobarbital—Rash—Sitagliptin—type 2 diabetes mellitus	0.000451	0.00277	CcSEcCtD
Pentobarbital—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000451	0.00277	CcSEcCtD
Pentobarbital—Headache—Glimepiride—type 2 diabetes mellitus	0.00045	0.00276	CcSEcCtD
Pentobarbital—Headache—Sitagliptin—type 2 diabetes mellitus	0.000448	0.00275	CcSEcCtD
Pentobarbital—Agitation—Losartan—type 2 diabetes mellitus	0.000445	0.00273	CcSEcCtD
Pentobarbital—Angioedema—Losartan—type 2 diabetes mellitus	0.000442	0.00271	CcSEcCtD
Pentobarbital—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000438	0.00269	CcSEcCtD
Pentobarbital—Shock—Metformin—type 2 diabetes mellitus	0.000437	0.00269	CcSEcCtD
Pentobarbital—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000436	0.00268	CcSEcCtD
Pentobarbital—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000436	0.00268	CcSEcCtD
Pentobarbital—Somnolence—Valsartan—type 2 diabetes mellitus	0.000434	0.00267	CcSEcCtD
Pentobarbital—Syncope—Losartan—type 2 diabetes mellitus	0.000434	0.00266	CcSEcCtD
Pentobarbital—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000428	0.00263	CcSEcCtD
Pentobarbital—Nausea—Glimepiride—type 2 diabetes mellitus	0.000426	0.00262	CcSEcCtD
Pentobarbital—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000425	0.00261	CcSEcCtD
Pentobarbital—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000425	0.00261	CcSEcCtD
Pentobarbital—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00042	0.00258	CcSEcCtD
Pentobarbital—GABRB3—islet of Langerhans—type 2 diabetes mellitus	0.000419	0.0382	CbGeAlD
Pentobarbital—Constipation—Valsartan—type 2 diabetes mellitus	0.000418	0.00256	CcSEcCtD
Pentobarbital—Hypotension—Metformin—type 2 diabetes mellitus	0.000415	0.00255	CcSEcCtD
Pentobarbital—Shock—Irbesartan—type 2 diabetes mellitus	0.000413	0.00253	CcSEcCtD
Pentobarbital—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000412	0.00253	CcSEcCtD
Pentobarbital—Anxiety—Losartan—type 2 diabetes mellitus	0.00041	0.00252	CcSEcCtD
Pentobarbital—CHRNA7—cardiovascular system—type 2 diabetes mellitus	0.000408	0.0372	CbGeAlD
Pentobarbital—Rash—Bromocriptine—type 2 diabetes mellitus	0.000408	0.00251	CcSEcCtD
Pentobarbital—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000408	0.0025	CcSEcCtD
Pentobarbital—Tension—Ramipril—type 2 diabetes mellitus	0.000407	0.0025	CcSEcCtD
Pentobarbital—Headache—Bromocriptine—type 2 diabetes mellitus	0.000406	0.00249	CcSEcCtD
Pentobarbital—CHRNA4—cardiovascular system—type 2 diabetes mellitus	0.000403	0.0367	CbGeAlD
Pentobarbital—Nervousness—Ramipril—type 2 diabetes mellitus	0.000403	0.00247	CcSEcCtD
Pentobarbital—CHRNA7—kidney—type 2 diabetes mellitus	0.0004	0.0364	CbGeAlD
Pentobarbital—Confusional state—Losartan—type 2 diabetes mellitus	0.000398	0.00244	CcSEcCtD
Pentobarbital—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000398	0.00244	CcSEcCtD
Pentobarbital—Somnolence—Metformin—type 2 diabetes mellitus	0.000395	0.00243	CcSEcCtD
Pentobarbital—Thiopental—CYP2E1—type 2 diabetes mellitus	0.000393	0.137	CrCbGaD
Pentobarbital—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000392	0.00241	CcSEcCtD
Pentobarbital—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000392	0.0024	CcSEcCtD
Pentobarbital—Shock—Losartan—type 2 diabetes mellitus	0.000388	0.00239	CcSEcCtD
Pentobarbital—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000385	0.00236	CcSEcCtD
Pentobarbital—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000381	0.00234	CcSEcCtD
Pentobarbital—Agitation—Ramipril—type 2 diabetes mellitus	0.000381	0.00234	CcSEcCtD
Pentobarbital—Constipation—Metformin—type 2 diabetes mellitus	0.00038	0.00233	CcSEcCtD
Pentobarbital—Angioedema—Ramipril—type 2 diabetes mellitus	0.000379	0.00233	CcSEcCtD
Pentobarbital—Vomiting—Glyburide—type 2 diabetes mellitus	0.000376	0.00231	CcSEcCtD
Pentobarbital—Rash—Glyburide—type 2 diabetes mellitus	0.000373	0.00229	CcSEcCtD
Pentobarbital—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000373	0.00229	CcSEcCtD
Pentobarbital—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000373	0.00229	CcSEcCtD
Pentobarbital—Syncope—Ramipril—type 2 diabetes mellitus	0.000372	0.00228	CcSEcCtD
Pentobarbital—Headache—Glyburide—type 2 diabetes mellitus	0.000371	0.00228	CcSEcCtD
Pentobarbital—Hypotension—Losartan—type 2 diabetes mellitus	0.000369	0.00227	CcSEcCtD
Pentobarbital—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000366	0.00225	CcSEcCtD
Pentobarbital—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000365	0.00224	CcSEcCtD
Pentobarbital—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.00036	0.0328	CbGeAlD
Pentobarbital—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00036	0.00221	CcSEcCtD
Pentobarbital—Constipation—Irbesartan—type 2 diabetes mellitus	0.000359	0.0022	CcSEcCtD
Pentobarbital—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000355	0.00218	CcSEcCtD
Pentobarbital—Anxiety—Ramipril—type 2 diabetes mellitus	0.000352	0.00216	CcSEcCtD
Pentobarbital—Nausea—Glyburide—type 2 diabetes mellitus	0.000352	0.00216	CcSEcCtD
Pentobarbital—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000351	0.00216	CcSEcCtD
Pentobarbital—Somnolence—Losartan—type 2 diabetes mellitus	0.000351	0.00216	CcSEcCtD
Pentobarbital—Phenobarbital—ABCC2—type 2 diabetes mellitus	0.000348	0.121	CrCbGaD
Pentobarbital—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000346	0.00212	CcSEcCtD
Pentobarbital—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.000344	0.0313	CbGeAlD
Pentobarbital—Confusional state—Ramipril—type 2 diabetes mellitus	0.000341	0.0021	CcSEcCtD
Pentobarbital—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000338	0.00207	CcSEcCtD
Pentobarbital—Constipation—Losartan—type 2 diabetes mellitus	0.000338	0.00207	CcSEcCtD
Pentobarbital—Rash—Gliclazide—type 2 diabetes mellitus	0.000335	0.00206	CcSEcCtD
Pentobarbital—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000335	0.00206	CcSEcCtD
Pentobarbital—Shock—Ramipril—type 2 diabetes mellitus	0.000333	0.00205	CcSEcCtD
Pentobarbital—Headache—Gliclazide—type 2 diabetes mellitus	0.000333	0.00204	CcSEcCtD
Pentobarbital—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000332	0.00204	CcSEcCtD
Pentobarbital—Secobarbital—CYP1A2—type 2 diabetes mellitus	0.000329	0.115	CrCbGaD
Pentobarbital—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000325	0.002	CcSEcCtD
Pentobarbital—Dizziness—Valsartan—type 2 diabetes mellitus	0.000323	0.00198	CcSEcCtD
Pentobarbital—Dizziness—Orlistat—type 2 diabetes mellitus	0.000319	0.00196	CcSEcCtD
Pentobarbital—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000318	0.029	CbGeAlD
Pentobarbital—Hypotension—Ramipril—type 2 diabetes mellitus	0.000316	0.00194	CcSEcCtD
Pentobarbital—Nausea—Gliclazide—type 2 diabetes mellitus	0.000316	0.00194	CcSEcCtD
Pentobarbital—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000312	0.00192	CcSEcCtD
Pentobarbital—Vomiting—Valsartan—type 2 diabetes mellitus	0.00031	0.00191	CcSEcCtD
Pentobarbital—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000309	0.0019	CcSEcCtD
Pentobarbital—Rash—Valsartan—type 2 diabetes mellitus	0.000308	0.00189	CcSEcCtD
Pentobarbital—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000308	0.00189	CcSEcCtD
Pentobarbital—Vomiting—Orlistat—type 2 diabetes mellitus	0.000307	0.00188	CcSEcCtD
Pentobarbital—Headache—Valsartan—type 2 diabetes mellitus	0.000306	0.00188	CcSEcCtD
Pentobarbital—Rash—Orlistat—type 2 diabetes mellitus	0.000304	0.00187	CcSEcCtD
Pentobarbital—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000304	0.00187	CcSEcCtD
Pentobarbital—Headache—Orlistat—type 2 diabetes mellitus	0.000302	0.00186	CcSEcCtD
Pentobarbital—Somnolence—Ramipril—type 2 diabetes mellitus	0.000301	0.00185	CcSEcCtD
Pentobarbital—GABRB3—pancreas—type 2 diabetes mellitus	0.000295	0.0269	CbGeAlD
Pentobarbital—Dizziness—Metformin—type 2 diabetes mellitus	0.000294	0.00181	CcSEcCtD
Pentobarbital—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000291	0.00179	CcSEcCtD
Pentobarbital—Nausea—Valsartan—type 2 diabetes mellitus	0.00029	0.00178	CcSEcCtD
Pentobarbital—Constipation—Ramipril—type 2 diabetes mellitus	0.00029	0.00178	CcSEcCtD
Pentobarbital—Nausea—Orlistat—type 2 diabetes mellitus	0.000287	0.00176	CcSEcCtD
Pentobarbital—Vomiting—Metformin—type 2 diabetes mellitus	0.000283	0.00174	CcSEcCtD
Pentobarbital—Rash—Metformin—type 2 diabetes mellitus	0.00028	0.00172	CcSEcCtD
Pentobarbital—Dermatitis—Metformin—type 2 diabetes mellitus	0.00028	0.00172	CcSEcCtD
Pentobarbital—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000279	0.00171	CcSEcCtD
Pentobarbital—Headache—Metformin—type 2 diabetes mellitus	0.000279	0.00171	CcSEcCtD
Pentobarbital—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000277	0.0017	CcSEcCtD
Pentobarbital—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000268	0.00164	CcSEcCtD
Pentobarbital—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000267	0.00164	CcSEcCtD
Pentobarbital—Rash—Irbesartan—type 2 diabetes mellitus	0.000265	0.00162	CcSEcCtD
Pentobarbital—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000264	0.00162	CcSEcCtD
Pentobarbital—Nausea—Metformin—type 2 diabetes mellitus	0.000264	0.00162	CcSEcCtD
Pentobarbital—Headache—Irbesartan—type 2 diabetes mellitus	0.000263	0.00161	CcSEcCtD
Pentobarbital—Dizziness—Losartan—type 2 diabetes mellitus	0.000261	0.0016	CcSEcCtD
Pentobarbital—CYP2A6—liver—type 2 diabetes mellitus	0.000252	0.023	CbGeAlD
Pentobarbital—Vomiting—Losartan—type 2 diabetes mellitus	0.000251	0.00154	CcSEcCtD
Pentobarbital—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000249	0.00153	CcSEcCtD
Pentobarbital—Nausea—Irbesartan—type 2 diabetes mellitus	0.000249	0.00153	CcSEcCtD
Pentobarbital—Rash—Losartan—type 2 diabetes mellitus	0.000249	0.00153	CcSEcCtD
Pentobarbital—Dermatitis—Losartan—type 2 diabetes mellitus	0.000249	0.00153	CcSEcCtD
Pentobarbital—Headache—Losartan—type 2 diabetes mellitus	0.000247	0.00152	CcSEcCtD
Pentobarbital—Thiopental—CYP3A4—type 2 diabetes mellitus	0.000247	0.0862	CrCbGaD
Pentobarbital—Phenobarbital—CYP2E1—type 2 diabetes mellitus	0.000244	0.0851	CrCbGaD
Pentobarbital—Nausea—Losartan—type 2 diabetes mellitus	0.000235	0.00144	CcSEcCtD
Pentobarbital—Phenobarbital—CYP1A2—type 2 diabetes mellitus	0.000232	0.081	CrCbGaD
Pentobarbital—Dizziness—Ramipril—type 2 diabetes mellitus	0.000224	0.00137	CcSEcCtD
Pentobarbital—Vomiting—Ramipril—type 2 diabetes mellitus	0.000215	0.00132	CcSEcCtD
Pentobarbital—Rash—Ramipril—type 2 diabetes mellitus	0.000213	0.00131	CcSEcCtD
Pentobarbital—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000213	0.00131	CcSEcCtD
Pentobarbital—Headache—Ramipril—type 2 diabetes mellitus	0.000212	0.0013	CcSEcCtD
Pentobarbital—Nausea—Ramipril—type 2 diabetes mellitus	0.000201	0.00123	CcSEcCtD
Pentobarbital—GABRB3—liver—type 2 diabetes mellitus	0.000187	0.0171	CbGeAlD
Pentobarbital—CYP2C19—liver—type 2 diabetes mellitus	0.000162	0.0148	CbGeAlD
Pentobarbital—Phenobarbital—CYP3A4—type 2 diabetes mellitus	0.000154	0.0536	CrCbGaD
Pentobarbital—CYP3A4—kidney—type 2 diabetes mellitus	0.000152	0.0138	CbGeAlD
Pentobarbital—CYP3A4—liver—type 2 diabetes mellitus	9.6e-05	0.00875	CbGeAlD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.18e-05	0.000183	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.13e-05	0.000179	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.09e-05	0.000176	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	2.09e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CDO1—type 2 diabetes mellitus	2.08e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPD2—type 2 diabetes mellitus	2.08e-05	0.000175	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PCK1—type 2 diabetes mellitus	2.07e-05	0.000174	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.06e-05	0.000173	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	2.03e-05	0.000171	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.03e-05	0.00017	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	2.02e-05	0.00017	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AK1—type 2 diabetes mellitus	1.99e-05	0.000167	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.98e-05	0.000166	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.96e-05	0.000165	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.95e-05	0.000164	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HK1—type 2 diabetes mellitus	1.94e-05	0.000163	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.9e-05	0.00016	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.89e-05	0.000158	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCKR—type 2 diabetes mellitus	1.87e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.87e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.87e-05	0.000157	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LPA—type 2 diabetes mellitus	1.87e-05	0.000157	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.83e-05	0.000154	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A4—type 2 diabetes mellitus	1.83e-05	0.000154	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MAT1A—type 2 diabetes mellitus	1.83e-05	0.000154	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.82e-05	0.000153	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.8e-05	0.000151	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALDOB—type 2 diabetes mellitus	1.79e-05	0.000151	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.79e-05	0.00015	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—G6PC—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HBA2—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ND1—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ENPP1—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.77e-05	0.000149	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.76e-05	0.000148	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.72e-05	0.000145	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCGR—type 2 diabetes mellitus	1.71e-05	0.000144	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GLP1R—type 2 diabetes mellitus	1.67e-05	0.00014	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.65e-05	0.000139	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—OXCT1—type 2 diabetes mellitus	1.62e-05	0.000136	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYTB—type 2 diabetes mellitus	1.62e-05	0.000136	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SRD5A1—type 2 diabetes mellitus	1.58e-05	0.000133	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.56e-05	0.000131	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTR—type 2 diabetes mellitus	1.52e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CPT1A—type 2 diabetes mellitus	1.52e-05	0.000128	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.51e-05	0.000127	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.51e-05	0.000127	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—STAR—type 2 diabetes mellitus	1.5e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD17B3—type 2 diabetes mellitus	1.5e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ACACA—type 2 diabetes mellitus	1.5e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NAMPT—type 2 diabetes mellitus	1.49e-05	0.000126	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LIPC—type 2 diabetes mellitus	1.49e-05	0.000125	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HBA1—type 2 diabetes mellitus	1.49e-05	0.000125	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCK—type 2 diabetes mellitus	1.49e-05	0.000125	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.48e-05	0.000124	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.45e-05	0.000122	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCC8—type 2 diabetes mellitus	1.44e-05	0.000121	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CBS—type 2 diabetes mellitus	1.44e-05	0.000121	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CETP—type 2 diabetes mellitus	1.43e-05	0.00012	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—COX2—type 2 diabetes mellitus	1.39e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC5A2—type 2 diabetes mellitus	1.39e-05	0.000117	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NCOA6—type 2 diabetes mellitus	1.36e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.36e-05	0.000115	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UCP3—type 2 diabetes mellitus	1.34e-05	0.000113	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—UCP2—type 2 diabetes mellitus	1.34e-05	0.000113	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD11B1—type 2 diabetes mellitus	1.34e-05	0.000113	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SREBF1—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SNAP25—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PSMD6—type 2 diabetes mellitus	1.33e-05	0.000112	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.32e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.32e-05	0.000111	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CTGF—type 2 diabetes mellitus	1.31e-05	0.00011	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.3e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMGCR—type 2 diabetes mellitus	1.3e-05	0.000109	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.27e-05	0.000107	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PCK1—type 2 diabetes mellitus	1.26e-05	0.000106	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.25e-05	0.000105	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.25e-05	0.000105	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.24e-05	0.000104	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.22e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.21e-05	0.000102	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.21e-05	0.000101	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.21e-05	0.000101	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.19e-05	0.0001	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HK1—type 2 diabetes mellitus	1.18e-05	9.92e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.18e-05	9.91e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.18e-05	9.88e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GCG—type 2 diabetes mellitus	1.16e-05	9.71e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.16e-05	9.71e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LPA—type 2 diabetes mellitus	1.14e-05	9.58e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HSD3B2—type 2 diabetes mellitus	1.14e-05	9.58e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—KCNJ11—type 2 diabetes mellitus	1.14e-05	9.58e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCKR—type 2 diabetes mellitus	1.14e-05	9.58e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.1e-05	9.26e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.1e-05	9.26e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.1e-05	9.21e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALDOB—type 2 diabetes mellitus	1.09e-05	9.19e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.06e-05	8.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.06e-05	8.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.06e-05	8.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.06e-05	8.94e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.06e-05	8.94e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.06e-05	8.92e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.04e-05	8.74e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.03e-05	8.66e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.03e-05	8.64e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GLP1R—type 2 diabetes mellitus	1.02e-05	8.54e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GNB3—type 2 diabetes mellitus	9.96e-06	8.37e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.96e-06	8.37e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—HMOX1—type 2 diabetes mellitus	9.91e-06	8.33e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAT—type 2 diabetes mellitus	9.78e-06	8.22e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.73e-06	8.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.73e-06	8.18e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOB—type 2 diabetes mellitus	9.49e-06	7.98e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	9.49e-06	7.97e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.48e-06	7.97e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	9.29e-06	7.81e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	9.29e-06	7.81e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—type 2 diabetes mellitus	9.24e-06	7.76e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	9.11e-06	7.66e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—LPL—type 2 diabetes mellitus	9.07e-06	7.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	9.06e-06	7.62e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	9.06e-06	7.61e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	9.06e-06	7.61e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	9.06e-06	7.61e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.05e-06	7.6e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.05e-06	7.6e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.05e-06	7.6e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	9e-06	7.57e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ADCY5—type 2 diabetes mellitus	8.88e-06	7.46e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GPX1—type 2 diabetes mellitus	8.84e-06	7.43e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	8.84e-06	7.43e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	8.74e-06	7.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.67e-06	7.29e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.67e-06	7.29e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CD36—type 2 diabetes mellitus	8.61e-06	7.24e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPP2CA—type 2 diabetes mellitus	8.51e-06	7.15e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.35e-06	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.35e-06	7.02e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.2e-06	6.89e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	8.16e-06	6.86e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	8.15e-06	6.85e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	8.12e-06	6.83e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	8.12e-06	6.83e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	8.12e-06	6.83e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.06e-06	6.78e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.06e-06	6.78e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.06e-06	6.78e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	8.01e-06	6.73e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	7.97e-06	6.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	7.9e-06	6.64e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.79e-06	6.55e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	7.76e-06	6.52e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	7.73e-06	6.5e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	7.63e-06	6.41e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	7.6e-06	6.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.58e-06	6.37e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	7.51e-06	6.31e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	7.43e-06	6.24e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	7.35e-06	6.17e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	7.35e-06	6.17e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	7.16e-06	6.02e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	7.13e-06	5.99e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.1e-06	5.97e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	7.04e-06	5.92e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	7.04e-06	5.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.86e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.86e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.86e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.86e-06	5.76e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	6.62e-06	5.56e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.57e-06	5.52e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	6.49e-06	5.46e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.11e-06	5.14e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.07e-06	5.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	6.07e-06	5.1e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	6.04e-06	5.08e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.96e-06	5.01e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	5.95e-06	5e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.79e-06	4.87e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.71e-06	4.79e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.69e-06	4.78e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	5.69e-06	4.78e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	5.63e-06	4.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.59e-06	4.7e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.59e-06	4.7e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	5.53e-06	4.65e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.48e-06	4.61e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.45e-06	4.58e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.45e-06	4.58e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.45e-06	4.58e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.41e-06	4.55e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	5.41e-06	4.55e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	5.39e-06	4.53e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.32e-06	4.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.26e-06	4.42e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	5.25e-06	4.41e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	5.21e-06	4.38e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	5.19e-06	4.36e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.98e-06	4.18e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.89e-06	4.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.89e-06	4.11e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.89e-06	4.11e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.88e-06	4.1e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.8e-06	4.03e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.75e-06	3.99e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.73e-06	3.97e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.65e-06	3.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.65e-06	3.91e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.63e-06	3.89e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4.58e-06	3.85e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.47e-06	3.76e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.42e-06	3.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.42e-06	3.71e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.24e-06	3.56e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.24e-06	3.56e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	4.04e-06	3.39e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.96e-06	3.33e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.65e-06	3.07e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.65e-06	3.07e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.63e-06	3.05e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.63e-06	3.05e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.59e-06	3.01e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.48e-06	2.93e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.47e-06	2.92e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.47e-06	2.92e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.39e-06	2.85e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.32e-06	2.79e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.25e-06	2.73e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.24e-06	2.73e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	3.17e-06	2.67e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.16e-06	2.65e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.12e-06	2.62e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.99e-06	2.52e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.94e-06	2.47e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.84e-06	2.39e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.8e-06	2.35e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.79e-06	2.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.75e-06	2.31e-05	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	2.62e-06	2.2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.43e-06	2.04e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.38e-06	2e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	1.83e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.09e-06	1.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.09e-06	1.75e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	1.6e-05	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-06	1.34e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.59e-07	8.06e-06	CbGpPWpGaD
